Regulatory approval of cancer risk-reducing (chemopreventive) drugs: Moving what we have learned into the clinic

Frank L. Meyskens, Gregory A. Curt, Dean E. Brenner, Gary Gordon, Ronald B. Herberman, Olivera Finn, Gary J. Kelloff, Samir N. Khleif, Caroline C. Sigman, Eva Szabo

Research output: Contribution to journal › Comment/debate › peer-review